Approvals/NMPA/Fluticasone Furoate and Vilanterol Trifenatate Powder for Inhalation (Ⅱ)

Approved

化学药品

Fluticasone Furoate and Vilanterol Trifenatate Powder for Inhalation (Ⅱ)

GLAXOSMITHKLINE (IRELAND) LIMITED🇨🇳 National Medical Products Administration

Approval Id: 8TELohrYrd6
Approval Number: 国药准字HJ20180044
Generic Name: 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅱ)
Generic Name En: Fluticasone Furoate and Vilanterol Trifenatate Powder for Inhalation (Ⅱ)
Brand Name: 万瑞舒
Drug Type: 化学药品
Dosage Form: 吸入制剂
Strength: 每泡含糠酸氟替卡松100μg与三苯乙酸维兰特罗25μg（按C₂₄H₃₃Cl₂NO₅计），递送剂量为糠酸氟替卡松92μg与三苯乙酸维兰特罗22μg（按C₂₄H₃₃Cl₂NO₅计）
Reg Date: 2023-06-07
Expired Date: 2028-06-06
Company Name: GLAXOSMITHKLINE (IRELAND) LIMITED
Company Detail Path: /organization/glaxosmithkline-ireland-limited

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Jun 7, 2023

Approval ID

8TELohrYrd6

Type

化学药品